{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:15:43Z","timestamp":1789208143914,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Ethics"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1472-6939-15-83","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T21:03:21Z","timestamp":1418159001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Shortcomings of protocols of drug trials in relation to sponsorship as identified by Research Ethics Committees: analysis of comments raised during ethical review"],"prefix":"10.1186","volume":"15","author":[{"given":"Marlies","family":"van Lent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard A","family":"Rongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk J","family":"Out","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,10]]},"reference":[{"key":"318_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-1586-3","volume-title":"Fundamentals of Clinical Trials","author":"L Friedman","year":"2010","unstructured":"Friedman L, Furberg C, DeMets D: Fundamentals of Clinical Trials. 2010, New York: Springer-Verlag New York Inc, 4","edition":"4"},{"key":"318_CR2","volume-title":"Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects","author":"World Medical Association","year":"2013","unstructured":"World Medical Association: Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. 2013, Fortaleza"},{"key":"318_CR3","volume-title":"International Ethical Guidelines for Biomedical Research Involving Human Subjects","author":"Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO)","year":"2002","unstructured":"Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO): International Ethical Guidelines for Biomedical Research Involving Human Subjects. 2002, Geneva"},{"issue":"20","key":"318_CR4","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1001\/jama.283.20.2701","volume":"283","author":"EJ Emanuel","year":"2000","unstructured":"Emanuel EJ, Wendler D, Grady C: What makes clinical research ethical?. JAMA. 2000, 283 (20): 2701-2711. 10.1001\/jama.283.20.2701.","journal-title":"JAMA"},{"issue":"6","key":"318_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.recesp.2011.12.017","volume":"65","author":"MC Martin-Arribas","year":"2012","unstructured":"Martin-Arribas MC, Rodriguez-Lozano I, Arias-Diaz J: Ethical review of research protocols: experience of a research ethics committee. Rev Esp Cardiol. 2012, 65 (6): 525-529. 10.1016\/j.recesp.2011.12.017.","journal-title":"Rev Esp Cardiol"},{"issue":"9","key":"318_CR6","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1590\/S1807-59322009000900002","volume":"64","author":"M Bueno","year":"2009","unstructured":"Bueno M, Brevidelli MM, Cocarelli T, Santos GM, Ferraz MA, Mion D: Reasons for resubmission of research projects to the research ethics committee of a university hospital in Sao Paulo, Brazil. Clinics. 2009, 64 (9): 831-836.","journal-title":"Clinics"},{"issue":"3","key":"318_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1136\/jme.25.3.274","volume":"25","author":"G Kent","year":"1999","unstructured":"Kent G: Responses by four Local Research Ethics Committees to submitted proposals. J Med Ethics. 1999, 25 (3): 274-277. 10.1136\/jme.25.3.274.","journal-title":"J Med Ethics"},{"issue":"2","key":"318_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/jme.2008.025940","volume":"35","author":"E Angell","year":"2009","unstructured":"Angell E, Dixon-Woods M: Do research ethics committees identify process errors in applications for ethical approval?. J Med Ethics. 2009, 35 (2): 130-132. 10.1136\/jme.2008.025940.","journal-title":"J Med Ethics"},{"issue":"8","key":"318_CR9","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S1470-2045(08)70184-0","volume":"9","author":"M Dixon-Woods","year":"2008","unstructured":"Dixon-Woods M, Angell E, Tarrant C, Thomas A: What do research ethics committees say about applications to do cancer trials?. Lancet Oncol. 2008, 9 (8): 700-701. 10.1016\/S1470-2045(08)70184-0.","journal-title":"Lancet Oncol"},{"issue":"11","key":"318_CR10","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1136\/adc.2009.172395","volume":"95","author":"E Angell","year":"2010","unstructured":"Angell E, Biggs H, Gahleitner F, Dixon-Woods M: What do research ethics committees say about applications to conduct research involving children?. Arch Dis Child. 2010, 95 (11): 915-917. 10.1136\/adc.2009.172395.","journal-title":"Arch Dis Child"},{"key":"318_CR11","volume-title":"Bad Pharma. How Drug Companies Mislead Doctors and Harm Patients","author":"B Goldacre","year":"2012","unstructured":"Goldacre B: Bad Pharma. How Drug Companies Mislead Doctors and Harm Patients. 2012, 4th Estate, London"},{"key":"318_CR12","first-page":"MR000033","volume":"12","author":"A Lundh","year":"2012","unstructured":"Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L: Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2012, 12: MR000033-","journal-title":"Cochrane Database Syst Rev"},{"issue":"16","key":"318_CR13","first-page":"279","volume":"107","author":"G Schott","year":"2010","unstructured":"Schott G, Pachl H, Limbach U, Gundert-Remy U, Ludwig WD, Lieb K: The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials. Dtsch Arztebl Int. 2010, 107 (16): 279-285.","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"318_CR14","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/j.1365-2753.2009.01335.x","volume":"16","author":"R Jones","year":"2010","unstructured":"Jones R, Younie S, Macallister A, Thornton J: A comparison of the scientific quality of publicly and privately funded randomized controlled drug trials. J Eval Clin Pract. 2010, 16 (6): 1322-1325. 10.1111\/j.1365-2753.2009.01335.x.","journal-title":"J Eval Clin Pract"},{"issue":"7","key":"318_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/medethics-2011-100020","volume":"38","author":"L Damen","year":"2012","unstructured":"Damen L, van Agt F, de Boo T, Huysmans F: Terminating clinical trials without sufficient subjects. J Med Ethics. 2012, 38 (7): 413-416. 10.1136\/medethics-2011-100020.","journal-title":"J Med Ethics"},{"issue":"10","key":"318_CR16","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1001\/jama.2014.1361","volume":"311","author":"B Kasenda","year":"2014","unstructured":"Kasenda B, Von Elm E, You J, Blumle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-Gonzalez I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Schandelmaier S, Xin S, Vandvik PO: Prevalence, characteristics, and publication of discontinued randomized trials. JAMA. 2014, 311 (10): 1045-1051. 10.1001\/jama.2014.1361.","journal-title":"JAMA"},{"key":"318_CR17","volume-title":"Annual Report 2011 Research Involving Human Subjects","author":"Central Committee on Research Involving Human Subjects (CCMO)","year":"2012","unstructured":"Central Committee on Research Involving Human Subjects (CCMO): Annual Report 2011 Research Involving Human Subjects. 2012, The Hague"},{"key":"318_CR18","unstructured":"Dutch Medical Research Involving Human Subjects Act (WMO). 1998, The Hague"},{"key":"318_CR19","unstructured":"Directive 2001\/20\/EC of the European Parliament and of the Council - EU Directive Good Clinical Practice. 2001, Luxembourg"},{"key":"318_CR20","volume-title":"ICH Harmonised Tripartite Guideline - Guideline for Good Clinical Practice E6","author":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use","year":"1996","unstructured":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use: ICH Harmonised Tripartite Guideline - Guideline for Good Clinical Practice E6. 1996"},{"key":"318_CR21","volume-title":"Revised Directive on the Assessment of Clinical Trial Agreements","author":"Central Committee on Research Involving Human Subjects (CCMO)","year":"2011","unstructured":"Central Committee on Research Involving Human Subjects (CCMO): Revised Directive on the Assessment of Clinical Trial Agreements. 2011, The Hague"},{"key":"318_CR22","volume-title":"Second Evaluation Dutch Medical Research Involving Human Subjects Act (WMO)","author":"MJ Stukart","year":"2012","unstructured":"Stukart MJ, Olsthoorn-Heim ETM, van de Vathorst S, van der Heide A, Tromp K, de Klerk C: Second Evaluation Dutch Medical Research Involving Human Subjects Act (WMO). 2012, The Hague: ZonMw"},{"issue":"12","key":"318_CR23","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.jclinepi.2013.06.020","volume":"66","author":"S Redmond","year":"2013","unstructured":"Redmond S, von Elm E, Blumle A, Gengler M, Gsponer T, Egger M: Cohort study of trials submitted to ethics committee identified discrepant reporting of outcomes in publications. J Clin Epidemiol. 2013, 66 (12): 1367-1375. 10.1016\/j.jclinepi.2013.06.020.","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"318_CR24","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1136\/jme.2008.024521","volume":"34","author":"A Blumle","year":"2008","unstructured":"Blumle A, Antes G, Schumacher M, Just H, von Elm E: Clinical research projects at a German medical faculty: follow-up from ethical approval to publication and citation by others. J Med Ethics. 2008, 34 (9): e20-10.1136\/jme.2008.024521.","journal-title":"J Med Ethics"},{"key":"318_CR25","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, Sterne JAC on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group: Chapter 8: Assessing Risk of Bias in Included Studies. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. 2011, The Cochrane Collaboration"},{"issue":"1","key":"318_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1525\/jer.2011.6.1.3","volume":"6","author":"L Abbott","year":"2011","unstructured":"Abbott L, Grady C: A systematic review of the empirical literature evaluating IRBs: what we know and what we still need to learn. J Empir Res Hum Res Ethics. 2011, 6 (1): 3-19. 10.1525\/jer.2011.6.1.3.","journal-title":"J Empir Res Hum Res Ethics"},{"issue":"11","key":"318_CR27","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1136\/jme.2005.014159","volume":"32","author":"E Angell","year":"2006","unstructured":"Angell E, Sutton AJ, Windridge K, Dixon-Woods M: Consistency in decision making by research ethics committees: a controlled comparison. J Med Ethics. 2006, 32 (11): 662-664. 10.1136\/jme.2005.014159.","journal-title":"J Med Ethics"},{"issue":"6","key":"318_CR28","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1016\/j.juro.2009.02.032","volume":"181","author":"BT Helfand","year":"2009","unstructured":"Helfand BT, Mongiu AK, Roehrborn CG, Donnell RF, Bruskewitz R, Kaplan SA, Kusek JW, Coombs L, McVary KT, on behalf of the MIST investigators: Variation in institutional review board responses to a standard protocol for a multicenter randomized, controlled surgical trial. J Urol. 2009, 181 (6): 2674-2679. 10.1016\/j.juro.2009.02.032.","journal-title":"J Urol"},{"issue":"3","key":"318_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/jp.2009.157","volume":"30","author":"AR Stark","year":"2010","unstructured":"Stark AR, Tyson JE, Hibberd PL: Variation among institutional review boards in evaluating the design of a multicenter randomized trial. J Perinatol. 2010, 30 (3): 163-169. 10.1038\/jp.2009.157.","journal-title":"J Perinatol"},{"key":"318_CR30","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.1186\/1472-6939-3-2","volume":"3","author":"F Goodyear-Smith","year":"2002","unstructured":"Goodyear-Smith F, Lobb B, Davies G, Nachson I, Seelau SM: International variation in ethics committee requirements: comparisons across five Westernised nations. BMC Med Ethics. 2002, 3: E2-10.1186\/1472-6939-3-2.","journal-title":"BMC Med Ethics"},{"issue":"585","key":"318_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3399\/bjgp11X567144","volume":"61","author":"S Dovey","year":"2011","unstructured":"Dovey S, Hall K, Makeham M, Rosser W, Kuzel A, Van Weel C, Esmail A, Phillips R: Seeking ethical approval for an international study in primary care patient safety. Br J Gen Pract. 2011, 61 (585): 197-204. 10.3399\/bjgp11X567144.","journal-title":"Br J Gen Pract"}],"container-title":["BMC Medical Ethics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6939-15-83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6939-15-83\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6939-15-83","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6939-15-83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T05:08:35Z","timestamp":1548133715000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedethics.biomedcentral.com\/articles\/10.1186\/1472-6939-15-83"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["318"],"URL":"https:\/\/doi.org\/10.1186\/1472-6939-15-83","relation":{},"ISSN":["1472-6939"],"issn-type":[{"value":"1472-6939","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"19 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"83"}}